Overexpression or mutation of the EGFR gene markedly enhances cell growth and proliferation, particularly in NSCLC [41] and breast cancer [32], making EGFR a well-established and effective therapeutic target for these diseases. The gene discussed is EGFR; the disease is breast cancer.